Achieve Life Sciences, Inc.
(NASDAQ : ACHV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.97%194.531.2%$602.72m
GILDGilead Sciences, Inc.
-0.62%67.150.9%$500.20m
CELGCelgene Corporation
1.51%67.761.2%$483.85m
BIIBBiogen Inc.
-0.27%318.631.3%$464.91m
ILMNIllumina, Inc.
2.70%309.203.5%$397.03m
REGNRegeneron Pharmaceuticals, Inc.
1.76%343.232.6%$296.75m
VRTXVertex Pharmaceuticals Incorporated
1.36%161.931.9%$262.04m
AAgilent Technologies, Inc.
0.67%67.971.5%$217.38m
ALXNAlexion Pharmaceuticals, Inc.
2.33%119.542.0%$205.22m
SRPTSarepta Therapeutics, Inc.
0.53%117.7915.4%$146.77m
LGNDLigand Pharmaceuticals Incorporated
2.07%151.9423.1%$140.24m
TSROTESARO, Inc.
-2.75%41.3114.4%$134.91m
EXASExact Sciences Corporation
0.71%65.1925.3%$131.44m
NKTRNektar Therapeutics
-2.78%37.065.6%$118.58m
INCYIncyte Corporation
0.11%63.662.5%$113.08m

Company Profile

Achieve Life Sciences, Inc. is a pharmaceutical company, which engages in the development of treatment option to help people battling nicotine addiction. It offers cytisine, which is a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company's activities also include research and development, raising capital, building management team, and seeking additional patent approvals. The company was founded by Caroline M. Loewy on May 12, 2015 and is headquartered in Bothell, WA.